Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada

This is a preview of subscription content, log in to check access.

Abbreviations

AdV:

Adenovirus

BTK:

Bruton’s tyrosine kinase

CAR-T:

Chimeric antigen receptor T cell

CCIC:

Canadian Cancer Immunotherapy Consortium

ccRCC:

Clear cell renal cell carcinoma

CMV:

Cytomegalovirus

CSK:

c-Src kinase

DC:

Dendritic cell

dPCR:

Digital polymerase chain reaction

EBV:

Epstein–Barr virus

INSERM:

Institut National de la Santé et de la Recherche Médicale

JAK3:

Janus kinase 3

JC:

John Cunningham virus

LAMP:

Lysosomal-associated membrane protein

LCK:

Lymphocyte-specific protein tyrosine kinase

MDSC:

Myeloid-derived suppressor cells

NGS:

Next-generation sequencing

NK:

Natural killer

NSCLC:

Non-small cell lung carcinoma

POG:

Personalized oncogenomics

TAM:

Tumor-associated macrophages

TCR:

T cell receptor

TIL:

Tumor-infiltrating lymphocytes

TLS:

Tertiary lymphoid structures

Treg:

Regulatory T cell

VST:

Virus-specific T cell

VZV:

Varicella zoster virus

YES:

Cellular homolog of the Yamaguchi sarcoma virus oncogene

Author information

Correspondence to Connie M. Krawczyk.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest. Connie Krawczyk participated in the organization of this CCIC meeting as coordinator of knowledge dissemination and outreach.

Additional information

Jeanette E. Boudreau, Maartje C.A. Wouters and Connie M. Krawczyk have equally contributed to this work.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Boudreau, J.E., Wouters, M.C.A. & Krawczyk, C.M. 8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada. Cancer Immunol Immunother 65, 235–241 (2016). https://doi.org/10.1007/s00262-015-1785-2

Download citation

Keywords

  • Immunotherapy
  • Cancer microenvironment
  • Checkpoint therapies
  • Monoclonal antibody therapy
  • Cancer genomics
  • Adoptive T cell therapy